Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias
- Status
- WITHDRAWN
- Phase
- PHASE1
Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
CART-38 in Adult AML and MM Patients
- Status
- TERMINATED
- Phase
- PHASE1
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Natural Killer (NK) Cell Therapy for B-Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL
- Status
- RECRUITING
- Phase
- PHASE4
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HPV16 E6 TCR T Cells for Cervical Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2